
“What you have here is the best of the best in the release of a clinical practice guideline. In the process, content, practicality and the rigor of its work, I really salute Mike (Fiore) and all the people who worked on the program, for what really should be a model for any clinic or medical practice.” --Dr. Tom Frieden, New York City Commissioner of Health.
|
Clinical Practice Guideline 2008 Update Published
Dr. Michael Fiore, chair of the Guideline Update Panel, spoke about his uncle who died from cancer directly resulting from smoking. Dr. Fiore discussed the thorough process in assembling the guideline update.
Dr. Scott Leischow, president of the Society for Research on Nicotine and Tobacco (SRNT), and Dr. Carlos Jaén, vice chair of the Guideline Update Panel, spoke about the need to help patients quit. Dr. Sue Curry, SRNT president-elect, discussed progress in the evidence base for tobacco treatments for teens and adults since the last update in 2000. Dr. C. Tracy Orleans, distinguished fellow and senior scientist from the Robert Wood Johnson Foundation, introduced two former smokers--Lois Smith of Rio, Wisconsin and Shirley Reimer from Milwaukee. Smith said she appreciated the help she received to quit eight years ago from the Wisconsin Tobacco Quit Line. Smith said her daughter, niece and nephew have followed her lead and also quit. Reimer said her grandchild begged her to quit and the Quit Line helped her to break free from her addiction to tobacco. "They really cared," Reimer said. "They helped me to quit."
The guideline represents nearly two years of work by a 24-member panel, and has been informed by the input from many members of the Society for Research on Nicotine and Tobacco. The Guideline Update is designed to provide an evidence-based blueprint for clinicians and health systems to assist patients who smoke to successfully quit tobacco use. The 2008 Guideline Update panel reviewed and analyzed more than 8,700 research articles on tobacco dependence published between 1975 and 2007, and includes the results of more than 50 meta-analyses. The draft document was reviewed by more than 90 independent peer reviewers, as well as members of the public through a Federal Register listing. It was sponsored by a consortium of eight Federal Government and nonprofit organizations: the Agency for Healthcare Research and Quality (AHRQ); Centers for Disease Control and Prevention (CDC); National Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI); National Institute on Drug Abuse (NIDA); Robert Wood Johnson Foundation (RWJF); The American Legacy Foundation; and the University of Wisconsin Center for Tobacco Research and Intervention. Copies of the Guideline and its companion pieces are available May 7 at http://www.surgeongeneral.gov/tobacco. In addition, an electronic summary of the Guideline written by the panel has been published in the American Journal of Preventive Medicine and a commentary has been published in the Journal of the American Medical Association (JAMA) by Dr. Carlos Jaén and Dr. Michael Fiore: "A Clinical Blueprint to Accelerate the Elimination of Tobacco Dependence." |
|
©
2008 UW-CTRI |
||||||||
|
|
|||||||||